New therapeutic approaches in PV

由 Falchi, Lorenzo, Newberry, Kate J., Verstovsek, Srdan
發表在 Clin Lymphoma Myeloma Leuk (2015)

Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea

由 Sever, Matjaz, Newberry, Kate J., Verstovsek, Srdan
發表在 Leuk Lymphoma (2014)

Conformational plasticity of the coiled coil domain of BmrR is required for bmr operator binding - the structure of unliganded BmrR

由 Kumaraswami, Muthiah, Newberry, Kate J., Brennan, Richard G.
出版 2010

Metal ion-mediated substrate-assisted catalysis in type II restriction endonucleases

由 Horton, Nancy C., Newberry, Kate Juliet, Perona, John J.
出版 1998

Structural origins of amino acid selection without editing by cysteinyl-tRNA synthetase

由 Newberry, Kate J., Hou, Ya-Ming, Perona, John J.
出版 2002

Crystal structure of the Bacillus subtilis anti-alpha, global transcriptional regulator, Spx, in complex with the α C-terminal domain of RNA polymerase

由 Newberry, Kate J., Nakano, Shunji, Zuber, Peter, Brennan, Richard G.
出版 2005

Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective

由 Desai, Madhav, Newberry, Kate, Ou, Zhishuo, Wang, Michael, Zhang, Liang
出版 2014

Genes Involved in Maintaining the Bone Marrow Stroma are Dysregulated in Patients with Myelofibrosis: Lenalidomide Treatment Upregulates SOCS3

由 Livun, Ana, Newberry, Kate J., Manshouri, Taghi, Kusec, Rajko, Verstovsek, Srdan
發表在 Anticancer Res (2015)

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis

由 Masarova, Lucia, Wang, Wei, Newberry, Kate J., Kantarjian, Hagop, Verstovsek, Srdan
發表在 Blood (2016)

THE ROLE OF THROMBOCYTAPHERESIS IN THE CONTEMPORARY MANAGEMENT OF HYPERTHROMBOCYTOSIS IN MYELOPROLIFERATIVE NEOPLASMS: A CASE-BASED REVIEW

由 Boddu, Prajwal, Falchi, Lorenzo, Hosing, Chitra, Newberry, Kate, Bose, Prithviraj, Verstovsek, Srdan
發表在 Leuk Res (2017)

Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy

由 Desai, Madhav, Newberry, Kate J, Romaguera, Jorge, Zhang, Liang, Ou, Zhishuo, Wang, Michael
出版 2013

Promoter Recognition by a Complex of Spx and the C-Terminal Domain of the RNA Polymerase α Subunit

由 Nakano, Michiko M., Lin, Ann, Zuber, Cole S., Newberry, Kate J., Brennan, Richard G., Zuber, Peter
出版 2010

Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience

由 Masarova, Lucia, Cherry, Mohamad, Newberry, Kate J., Estrov, Zeev, Cortes, Jorge E., Kantarjian, Hagop M., Verstovsek, Srdan
發表在 Leuk Lymphoma (2015)

Comorbidities predict worse prognosis in patients with primary myelofibrosis

由 Newberry, Kate J., Naqvi, Kiran, Nguyen, Khanh T., Cardenas-Turanzas, Marylou, Tanaka, Maria Florencia, Pierce, Sherry, Verstovsek, Srdan
發表在 Cancer (2014)

Structures of BmrR-Drug Complexes Reveal a Rigid Multidrug Binding Pocket and Transcription Activation through Tyrosine Expulsion

由 Newberry, Kate J., Huffman, Joy L., Miller, Marshall C., Vazquez-Laslop, Nora, Neyfakh, Alex A., Brennan, Richard G.
出版 2008

Association of Lymphoid Malignancies and Philadelphia-Chromosome Negative Myeloproliferative Neoplasms: Clinical Characteristics, Therapy and Outcome

由 Masarova, Lucia, Newberry, Kate J., Pierce, Sherry A., Estrov, Zeev, Cortes, Jorge E., Kantarjian, Hagop M., Verstovsek, Srdan
發表在 Leuk Res (2015)

Therapy-related myelofibrosis does not appear to exist

由 Masarova, Lucia, Todisco, Gabriele, Manshouri, Taghi, Newberry, Kate J., Cortes, Jorge E., Kantarjian, Hagop M., Estrov, Zeev, Verstovsek, Srdan
發表在 Blood Adv (2017)

Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median fo...

由 Masarova, Lucia, Patel, Keyur P., Newberry, Kate J., Cortes, Jorge, Borthakur, Gautam, Konopleva, Marina, Estrov, Zeev, Kantarjian, Hagop, Verstovsek, Srdan
發表在 Lancet Haematol (2017)

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

由 Masarova, Lucia, Bose, Prithviraj, Daver, Naval, Pemmaraju, Naveen, Newberry, Kate J., Manshouri, Taghi, Cortes, Jorge, Kantarjian, Hagop M, Verstovsek, Srdan
發表在 Leuk Res (2017)

ETV6-FLT3 Fusion Gene–Positive, Eosinophilia-Associated Myeloproliferative Neoplasm Successfully Treated with Sorafenib and Allogeneic Stem Cell Transplant

由 Falchi, Lorenzo, Mehrotra, Meenakshi, Newberry, Kate J., Lyle, Lindsey M., Lu, Gary, Patel, Keyur P., Luthra, Raja, Popat, Uday, Verstovsek, Srdan
發表在 Leukemia (2014)